Agranulocytosis, acquired:

Description Percentage

Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period.

100
Description Percentage

Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter ([micro]l) but less than /[micro]l; or infections recurring, on average, at least once every three months per 12-month period

60
Description Percentage

Requiring intermittent myeloid growth factors to maintain ANC greater than /[micro]l; or infections recurring, on average, at least once per 12-month period but less than once every three months per 12-month period

30
Description Percentage

Requiring continuous medication (e.g., antibiotics for control; or requiring intermittent use of a myeloid growth factor to maintain ANC greater than or equal to /[micro]l

10

Note: A 100 percent evaluation for bone marrow transplant shall be assigned as of the date of hospital admission and shall continue with a mandatory VA examination six months following hospital discharge. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of Sec.   3.105(e) of this chapter.

Need help with Medical Compensation? If your disability claim is not clearly supported by your medical records along with evidence, your claim can be denied. We have helped thousands of Veterans claim the compensation they deserve.

Get More Info